• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchiBio
    Picture of iBio logo

    IBIO — iBio Share News

    $0.720.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $46.16m
    • Enterprise Value
      -$41.88m
    • Revenue
      $0.10m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IBIO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IBIO Dividends
    • Brief: Ibio Inc Enters Exclusive License Agreement With AstralBio

      22/04/2025 22:58
    • Brief: Ibio Inc - On Track For Regulatory Submission For Ibio-600 In Q1 2026

      07/04/2025 12:41
    • Brief: Ibio And Astralbio Provide Update On Myostatin Program For Obesity

      10/10/2024 13:08
    • Brief: Ibio Appoints Kristi Sarno As Senior Vice President Of Business Development

      12/08/2024 22:19
    • Brief: Ibio Inc Says Entered Into Purchase, Sale Agreement, Dated As Of May 17, With Board Of Regents Of Texas A&M University System

      20/05/2024 13:14
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.